Dr. Matthew Wright, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,453 | 22 | 85.5% |
| Education | $414.92 | 5 | 14.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $465.80 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $372.53 | 4 | $0 (2024) |
| Seagen Inc. | $348.86 | 3 | $0 (2022) |
| Astellas Pharma US Inc | $314.97 | 4 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $246.89 | 2 | $0 (2022) |
| Incyte Corporation | $241.85 | 2 | $0 (2022) |
| Gen-Probe, Inc. | $149.67 | 1 | $0 (2023) |
| Avita Medical Americas, LLC | $147.85 | 1 | $0 (2023) |
| Daiichi Sankyo Inc. | $125.00 | 1 | $0 (2024) |
| Stemline Therapeutics Inc. | $121.85 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $373.51 | 3 | Gilead Sciences, Inc. ($130.22) |
| 2023 | $917.41 | 8 | AstraZeneca Pharmaceuticals LP ($241.58) |
| 2022 | $1,083 | 10 | Seagen Inc. ($348.86) |
| 2021 | $221.00 | 2 | JAZZ PHARMACEUTICALS INC. ($111.75) |
| 2020 | $85.44 | 1 | Celgene Corporation ($85.44) |
| 2019 | $174.99 | 2 | Astellas Pharma US Inc ($174.99) |
| 2017 | $12.66 | 1 | AstraZeneca Pharmaceuticals LP ($12.66) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $130.22 | General |
| 02/29/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $118.29 | General |
| 12/12/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Oncology | ||||||
| 12/07/2023 | Gen-Probe, Inc. | BTX (Device) | Food and Beverage | In-kind items and services | $149.67 | General |
| Category: Diagnostics | ||||||
| 10/18/2023 | Avita Medical Americas, LLC | Recell (Device) | Food and Beverage | Cash or cash equivalent | $147.85 | General |
| Category: PLASTIC SURGERY | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $119.74 | General |
| Category: Oncology | ||||||
| 07/25/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $121.16 | General |
| Category: ONC | ||||||
| 05/02/2023 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $121.85 | General |
| Category: Oncology | ||||||
| 03/21/2023 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | Cash or cash equivalent | $119.74 | General |
| Category: Oncology | ||||||
| 02/22/2023 | Biogen, Inc. | Spinraza (Biological) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Neurology | ||||||
| 12/06/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $81.99 | General |
| 12/06/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $57.99 | General |
| 10/27/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $119.74 | General |
| Category: ONC | ||||||
| 10/20/2022 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $124.72 | General |
| Category: Oncology | ||||||
| 06/08/2022 | Seagen Inc. | — | Education | In-kind items and services | $99.95 | General |
| 06/03/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $94.68 | General |
| Category: ONC | ||||||
| 04/27/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $123.78 | General |
| Category: Oncology | ||||||
| 03/31/2022 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $124.19 | General |
| Category: Oncology | ||||||
| 03/10/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $123.11 | General |
| 02/15/2022 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $132.60 | General |
| Category: Hematology/Oncology | ||||||
| 11/11/2021 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $109.25 | General |
| Category: Hematology/Oncology | ||||||
| 11/03/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | Cash or cash equivalent | $111.75 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 02/19/2020 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | Cash or cash equivalent | $85.44 | General |
| Category: Hematology | ||||||
| 09/17/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 184 | 253 | $113,188 | $23,754 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 60 | 99 | $52,899 | $10,491 | 19.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 43 | 43 | $28,788 | $5,900 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 42 | $11,134 | $3,031 | 27.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 16 | 28 | $14,898 | $3,001 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 17 | $2,909 | $759.26 | 26.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 18 | 24 | $2,560 | $571.68 | 22.3% |
About Dr. Matthew Wright, MD
Dr. Matthew Wright, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2016. The National Provider Identifier (NPI) number assigned to this provider is 1164886701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Wright, MD has received a total of $2,868 in payments from pharmaceutical and medical device companies, with $373.51 received in 2024. These payments were reported across 27 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,453).
As a Medicare-enrolled provider, Wright has provided services to 184 Medicare beneficiaries, totaling 253 services with total Medicare billing of $23,754. Data is available for 1 year (2023–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Medical Oncology
- Location Houston, TX
- Active Since 04/10/2016
- Last Updated 08/08/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1164886701
Products in Payments
- Trodelvy (Drug) $335.58
- TUKYSA (Drug) $248.91
- JAKAFI (Drug) $241.85
- BTX (Device) $149.67
- Recell (Device) $147.85
- Enhertu (Drug) $125.00
- OPDIVO (Biological) $123.78
- Orserdu (Drug) $121.85
- ENHERTU (Biological) $121.84
- LYNPARZA (Drug) $119.74
- VERZENIO (Drug) $119.74
- ZEPZELCA (Drug) $111.75
- Revlimid (Drug) $85.44
- Spinraza (Biological) $15.56
- BRILINTA (Drug) $12.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Houston
Sandeep Sahay, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $366,850
Diego Marines Copado, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $287,975
Dr. Eddie Patton, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $235,342
Naveen Pemmaraju, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $198,556
Laila Tabatabai, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $194,524
Syed Naqvi, M.d./M.b.a, M.D./M.B.A
Student in an Organized Health Care Education/Training Program — Payments: $144,401